Mid-term Clinical Outcome of Total Knee Arthroplasty with Domestic A3 Posterior Stabilized Prosthesis

X Geng,H Tian,Y Li,M W Zhao,X G Wang,Y P Liang,K Zhang,Z J Liu
DOI: https://doi.org/10.3760/cma.j.issn.0376-2491.2018.47.012
2018-01-01
Abstract:Objective To observe the mid-term clinical outcome of total knee arthroplasty ( TKA) with domestic A3 posterior stabilized prosthesis .Methods The clinical data of 342 patients ( 438 knees ) who underwent primary TKA by the same surgeon from June 2012 to December 2013 in Peking University Third Hospital were retrospectively collected .The patients were divided into 2 groups according to the type of prosthesis:107 patients (137 knees) with domestic A3 prosthesis, as domestic group; 235 patients (301 knees) with a kind of imported prosthesis, as the control group.In the end, 311 patients (390 knees) received complete follow-up.The postoperative knee maximum flexion angle , postoperative Hospital for Special Surgery Knee Score ( HSS) and the Western Ontario and McMaster Universities Osteoarthritis Index ( WOMAC ) , postoperative coronal mechanical axis alignment and hospitalization costs were compared between the groups.Paired t-test was used to compare the preoperative and postoperative data in the same group, and independent sample t-test was used to compare the data between the two groups at the same time points.Results The average follow-up time of all the patients was (5.6 ±1.1) years, and it was averaged for 64.8 months in the domestic group and 68.2 months in the control group.There was no significant difference in the HSS score and WOMAC score , the knee maximum flexion angle , and coronal mechanical axis alignment at the 3 months postoperatively and at the end of follow-up between the two groups ( t =-0.890, -1.610, 1.740, 0.620, all P >0.05 ) .In 2012, the average hospital cost was ( 24879 ± 1627) yuan/knee in the domestic group and it was (49611 ±1589) yuan/knee in the control group (t=-48.902, P<0.01 ) .In 2013, it was ( 38393 ±2773 ) yuan/knee in the domestic group , and was (55931 ±3533) yuan/knee in the control group (t=-14.795, P<0.01).Conclusion It indicates that the domestic A3 posterior stabilized prosthesis brings comparable mid-term results with the imported prothesis and it reduces medical costs remarkably .
What problem does this paper attempt to address?